PA101

DRUG2 trials

Sponsors

Patara Pharma

Conditions

Indolent Systemic MastocytosisMastocytosisRefractory Chronic CoughSystemic Mastocytosis

Phase 2

Treatment of Refractory Chronic Cough With PA101

CompletedNCT02412020

Patara PharmaRefractory Chronic Cough

Start: 2015-02-28End: 2016-02-29Updated: 2016-02-22

Treatment of Indolent Systemic Mastocytosis With PA101

CompletedNCT02478957

Patara PharmaIndolent Systemic Mastocytosis, Mastocytosis, Systemic Mastocytosis

Start: 2015-06-30End: 2016-06-30Updated: 2016-09-29

Related Papers

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.

2017-09-0883 citations